Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SYDNEY, Australia, June 21, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q) (Company), the Company developing new classes of synthetic anti-infectives, has accepted an...
-
Highlights: RECCE® 327 (R327) Mechanism of Action ‘unlike that of any antibiotic seen before’ with multiple mechanisms identified in independent study - to be presented at upcoming World Microbe...
-
Summary: Further study completed at the Doherty Institute as part of SARS-CoV-2 Antiviral Screening Program calculates IC50 of RECCE® 327 (R327) to be 2,046 PPM and the CC50 for R327 to be 5108...
-
Highlights: More than 99.9% effective against full suite of ESKAPE pathogens, within hours of exposure to RECCE® 327 (R327) in independent bacterial efficacy studiesR327 remains effective against...
-
Highlights: Positive sinusitis infection data indicated in animal study Study supports broad spectrum potential of Recce’s anti-infective compounds against Streptococcus pneumoniae (S. pneumoniae)...
-
Highlights: RECCE® 327 included in The Pew Charitable Trusts’ annual assessment of non-traditional antibiotic treatment in clinical developmentRECCE® 327 is the only synthetic polymer drug candidate...
-
Shares now trading on major German Trading Exchanges Shares trade under code: R9QNo related capital raising - trade of existing securities with trade volume to increase on Australian Stock Exchange...
-
Highlights: Broadens institutional and retail investor base across EU and enables access to additional capital markets No related capital raising - trade of existing securities with trade...
-
Highlights: RECCE® 327, a synthetic anti-infective 99.9% efficacious in confirmatory in-vitro screening assay against SARS-CoV-2 virusSARS-CoV-2 virus no longer detectable by virus titration at 4,000...
-
Highlights: Phase I/II trial agreement with Fiona Stanley Hospital (Burns Unit) in Perth Western AustraliaStudy led by world leading burn treatment specialistsStudy will assess safety and efficacy of...